Drug Profile
Interferon alpha-2b biosimilar - Intas Biopharmaceuticals
Alternative Names: Intalfa; Recombinant interferon alpha-2b - Intas BiopharmaceuticalsLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Intas Biopharmaceuticals
- Class Antineoplastics; Antivirals; Interferons; Recombinant proteins
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Cancer; Hepatitis B; Hepatitis C
Most Recent Events
- 30 Apr 2007 Launched for Cancer in India (Parenteral)
- 30 Apr 2007 Launched for Hepatitis B in India (Parenteral)
- 30 Apr 2007 Launched for Hepatitis C in India (Parenteral)